Literature DB >> 12908521

Deletion mapping of chromosome 1 in early onset and late onset breast tumors--a comparative study in eastern India.

Neelanjana Chunder1, Syamsundar Mandal, Debasis Basu, Anup Roy, Susanta Roychoudhury, Chinmay Kumar Panda.   

Abstract

Younger women exhibit more aggressive pathologic features of breast cancer (BC) compared to their older counterparts. Young age has been shown to be an independent predictor of adverse prognosis. These findings have raised the question of whether these differences are also present at the genetic level. Twenty-five early onset (age < or = 40 years) tumors including 4 bilateral tumors, and 26 late onset (>40 years) breast tumors, including 2 bilateral tumors, were examined for loss of heterozygosity (LOH) at chromosome 1 using 11 polymorphic microsatellite markers. A comparative study revealed high frequencies of LOH in chr. 1p36 (61%), 1p31.3 (40%), 1p21.3 (50%) and 1q22-23.2 (56%) in a younger group, and chr. 1p36 (46%), 1p34.2 (48%), and 1q22-23.2 (52%) in an older group. These differences in LOH frequency in these two age groups were significant for chr. 1p21.3 (p = 0.025) only. These data suggest that the deletion pattern in early onset breast tumors is not fully identical to late onset breast tumors. Similar differential deletion patterns of LOH in the 5 highly deleted regions were seen in premenopausal and postmenopausal groups. An association was seen between LOH at chr. 1p34.2 and chr. 1q22-23.2 and higher grade of the tumors in older women. Among the highly deleted regions, the deletion at chr. 1p36 was found to occur early in both groups because of common allelic loss in the bilateral tumors.

Entities:  

Mesh:

Year:  2003        PMID: 12908521     DOI: 10.1078/0344-0338-00423

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Expression of PIK3IP1 in the murine uterus during early pregnancy.

Authors:  Hanna E Teasley; Hye Jin Chang; Tae Hoon Kim; Bon Jeong Ku; Jae-Wook Jeong
Journal:  Biochem Biophys Res Commun       Date:  2017-12-28       Impact factor: 3.575

Review 2.  The roles of ARID1A in gynecologic cancer.

Authors:  Tsui-Lien Mao; Ie-Ming Shih
Journal:  J Gynecol Oncol       Date:  2013-10-02       Impact factor: 4.401

3.  Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Cancer       Date:  2008-11-06       Impact factor: 27.401

Review 4.  ARID1A gene mutation in ovarian and endometrial cancers (Review).

Authors:  Takashi Takeda; Kouji Banno; Ryuichiro Okawa; Megumi Yanokura; Moito Iijima; Haruko Irie-Kunitomi; Kanako Nakamura; Miho Iida; Masataka Adachi; Kiyoko Umene; Yuya Nogami; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Oncol Rep       Date:  2015-11-16       Impact factor: 3.906

5.  Proline-Rich Acidic Protein 1 (PRAP1) is a Target of ARID1A and PGR in the Murine Uterus.

Authors:  Tae Hoon Kim; Jae-Wook Jeong
Journal:  Dev Reprod       Date:  2019-09-30

6.  ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.

Authors:  Nozomi Yachida; Kosuke Yoshihara; Kazuaki Suda; Hirofumi Nakaoka; Haruka Ueda; Kentaro Sugino; Manako Yamaguchi; Yutaro Mori; Kaoru Yamawaki; Ryo Tamura; Tatsuya Ishiguro; Masanori Isobe; Teiichi Motoyama; Ituro Inoue; Takayuki Enomoto
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

7.  Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU.

Authors:  Tangshun Wang; Xiang Gao; Kexin Zhou; Tao Jiang; Shuang Gao; Pengzhou Liu; Ximeng Zuo; Xiaoguang Shi
Journal:  Int J Mol Med       Date:  2020-09-15       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.